Sami Mansfield
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Sami Mansfield
Jun 29, 2024, 10:19 |
Blog
Sami Mansfield: A recent review examines the impact of energy balance on triple-negative breast cancer
Sami Mansfield shared a post on LinkedIn: “Research question - Does a healthy weight and…
Jun 13, 2024, 15:13 |
Blog
Sami Mansfield: Rise in Colorectal Cancer Among Kids and Teens
Sami Mansfield shared a post on their LinkedIn: ''Alarming Rise in Colorectal Cancer Among Kids…
Jun 11, 2024, 12:10 |
Blog
Michelle Kirschner: Sami Mansfield will speak about Exercise Oncology for the Cancer Survivorship Provider Network
Michelle Kirschner recently shared a post by Sami Mansfield, Founder of Cancer Wellness for Life,…
Apr 12, 2024, 10:55 |
Drugs
Sami Mansfield: How Common Medications Impact Exercise
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: "Hello, fellow health and fitness…
Apr 7, 2024, 12:39 |
Blog
Sami Mansfield: The critical role of lifestyle medicine and the risk factors of Obesity and Alcohol in colorectal cancer
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: "While colorectal cancer awareness month…
Apr 1, 2024, 00:34 |
Insight
Sami Mansfield: New Insights on Exercise & Metastatic Breast Cancer
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: “New Insights on Exercise &…
Nov 5, 2023, 04:48 |
Blog
Sami Mansfield: Introducing the NEW "be ACTIVE" Program
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: "It's here! Introducing the…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube